INTRODUCTION
============

G protein--coupled receptors (GPCRs), also known as seven-transmembrane receptors (7TMRs), constitute a large family of cell surface proteins, with \>800 members ([@B1]). GPCRs display overall conserved 7TM architecture, activation mechanisms, signaling outcomes, and regulatory paradigms ([@B2]). Agonist binding results in conformational changes in the receptor, G protein coupling, and generation of second messengers such as Ca^2+^, cAMP, and inositol triphosphate ([@B2]). This is followed by the phosphorylation of serine and threonine residues in the carboxyl terminus and intracellular loops by various kinases ([@B3]; [@B8]). Activated and phosphorylated receptors recruit multifunctional adaptor proteins---arrestins---which are responsible for preventing further G protein coupling to the receptors and thereby desensitize the G protein response ([@B22]). There are four members in the arrestin family, arrestins-1--4; of these, arrestins-2 and 3 are also referred to as β-arrestin 1 (βarr1) and β-arrestin 2 (βarr2), respectively ([@B18]). In addition to terminating G protein signaling, βarrs are well established to mediate receptor endocytosis via a clathrin-dependent mechanism ([@B12]) and also trigger G protein--independent signaling responses downstream of activated GPCRs ([@B5]; [@B30]; [@B36]). βarrs mediate receptor desensitization by sterically hindering G protein coupling to the receptor ([@B6]; [@B28]; [@B37]; [@B14]), and their ability to facilitate receptor endocytosis and G protein--independent signaling arises primarily from their scaffolding properties ([@B19]; [@B5]). For example, βarrs can scaffold components of endocytosis machinery such as clathrin and β2 adaptin subunit of AP2 to mediate agonist-induced GPCR endocytosis ([@B7]; [@B17]). However, for some GPCRs, βarr-independent endocytosis has also been reported ([@B38]). Similarly, βarrs can also scaffold various components of extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) cascades, such as Raf1, MEK1, and ERK2, in order to facilitate G protein--independent ERK MAPK activation ([@B23]; [@B4]).

Arrestins interact with GPCRs through two sets of interactions, one involving the phosphorylated carboxyl terminus of the receptor (also referred to as the receptor tail) and the other involving the receptor core ([@B9], [@B10]; [@B32]). A recently determined crystal structure of βarr1 bound to a phosphopeptide corresponding to the carboxyl terminus of the vasopressin receptor (V~2~R) has directly revealed the interaction of receptor-attached phosphates with positively charged residues in the N-domain of βarr1 ([@B31]). In addition, the crystal structure of a rhodopsin--arrestin-1 fusion protein identified the regions in the receptor and arrestin-1 involved in making the core interaction ([@B14], [@B13]). Furthermore, a combination of single-particle electron microscopy (EM), hydrogen-deuterium exchange, and cross-linking resulted in direct visualization of biphasic interaction between a modified β2-adrenergic receptor (β~2~AR) and βarr1 ([@B32]; [Figure 1A](#F1){ref-type="fig"}). It is generally believed that complete engagement of βarrs with GPCRs involving both the tail and the core interaction is likely to be required for functional outcomes. However, previous studies reported that interaction with isolated phosphopeptides corresponding to the carboxyl terminus of GPCRs is sufficient to trigger activation-dependent conformational changes in arrestins ([@B27]; [@B39]; [@B26]). For βarrs, binding of phosphopeptide also results in enhanced interaction with clathrin heavy chain in vitro ([@B39]; [@B26]). In addition, crystallization attempts of p44, a carboxyl-terminus--truncated splice variant of arrestin-1, with phosphorylated opsin also resulted in an "active-like" conformation in the crystal structure despite the lack of cocrystallization with opsin ([@B15]). This observation suggests that transient interaction with phosphorylated receptor might be sufficient to prime arrestin-1 activation. Finally, single-particle EM analysis of a complex of βarr1 with a modified β~2~AR stabilized with an antibody fragment revealed a significant population in which the receptor and βarr1 are associated only through the phosphorylated receptor tail ([@B32]). This observation suggests that physical formation of a receptor-βarr complex may not necessarily require the core interaction. Taken together, these data indicate that engagement of arrestins to phosphorylated receptor tail even in the absence of the core interaction might be sufficient to trigger some functional outcomes.

![Characterization of a V~2~R mutant with truncated ICL3 loop. (A) Schematic representation of biphasic GPCR-βarr interaction, which involves phosphorylated carboxyl terminus (receptor tail) and intracellular surface of the transmembrane receptor core. Here tail-only engaged receptor-βarr complex is referred to as "partially engaged complex," and "fully engaged complex" refers to involvement of both set of interactions (tail plus core). (B) Schematic representation of three V~2~R constructs containing truncated ICL3: V~2~R^Δ227--265^, V~2~R^Δ230--262^, and V~2~R^Δ233--259^. Black dotted lines indicate sequence that has been deleted. V~2~R^Δ233--259^ construct, highlighted by the red dashed box, is referred to as V~2~R^ΔICL3^. (C) N-terminal FLAG-tagged V~2~R constructs were expressed in HEK-293 cells, and their surface and total expression was measured by a whole-cell ELISA as described in *Materials and Methods*. V~2~R^Δ233--259^ (referred to as V~2~R^ΔICL3^) exhibited robust surface expression, and therefore it was used in subsequent experiments. Expression data of V~2~R constructs is normalized with respect to V~2~R^WT^, which is treated as 100%. pcDNA3.1 (empty vector)-transfected cells were used as a negative control. (D) Agonist-induced cAMP response downstream of V~2~R^WT^ and V~2~R^ΔICL3^ in HEK-293T cells as measured by the GloSensor assay. Both V~2~R^WT^ and V~2~R^ΔICL3^ exhibit robust cAMP generation, and the EC~50~ of V~2~R^ΔICL3^ is approximately an order of magnitude higher than that of V~2~R^WT^. Data represent two independent experiments each carried out in triplicate and normalized with respect to maximal response of V~2~R^WT^. (E) Confocal microscopy of HEK-293 cells expressing either V~2~R^WT^ or V~2~R^ΔICL3^ with βarr1-YFP. Agonist stimulation leads to accumulation of endocytotic vesicles, which indicates recruitment of βarr1 to activated receptor and subsequent receptor internalization. Scale bar, 10 μm.](1003fig1){#F1}

We recently demonstrated that for a chimeric β~2~-adrenergic receptor that harbors the carboxyl terminus of the vasopressin receptor (referred to as β~2~V~2~R), engagement of the core interaction with βarr1 is not required for endocytosis and ERK MAPK activation ([@B16]). However, it remains unclear whether even for a native GPCR, full engagement with βarrs may not be essential for functional outcomes. Accordingly, here we sought to isolate a partially engaged complex of βarr1 with the human V~2~R associated only through the phosphorylated carboxyl terminus and compare its functional properties with a fully engaged V~2~R-βarr1 complex in vitro and in a cellular context. We found that a V~2~R construct defective in making the core interaction not only forms a stable complex with βarr1 in solution but also efficiently undergoes agonist-induced endocytosis and triggers ERK MAPK activation.

RESULTS AND DISCUSSION
======================

A V~2~R mutant with truncated third intracellular loop efficiently recruits βarr1
---------------------------------------------------------------------------------

Chemical cross-linking on a preformed β~2~V~2~R-βarr1 complex using a heterobifunctional amine-reactive cross-linker and a disulfide trapping strategy identified close proximity between the third intracellular loop (ICL3) in the receptor and the finger loop in βarr1 ([@B32]). Similarly, the crystal structure of rhodopsin--arrestin-1 fusion protein and site-specific disulfide cross-linking experiments also suggest that ICL3 in the receptor and finger loop in arrestin-1 are closely positioned during their interaction ([@B14]). Because this proximal positioning of receptor ICL3 and βarr finger loop forms a key interface for the core interaction, we hypothesized that V~2~R mutants with truncated ICL3 may not engage the core interaction with βarrs. Complexes of such V~2~R mutants with βarr1, if formed, should represent partially engaged complexes involving only the tail interaction (i.e., through the phosphorylated carboxyl terminus). Accordingly, we first generated a series of ICL3-truncated V~2~R constructs ([Figure 1B](#F1){ref-type="fig"}) and measured their total and surface expression in transfected HEK-293 cells using a cell-based enzyme-linked immunosorbent assay (ELISA; [Figure 1C](#F1){ref-type="fig"}). We observed that a V~2~R construct with H^233^--G^259^ truncation in ICL3 expresses robustly at the cell surface ([Figure 1, B and C](#F1){ref-type="fig"}, red dotted box). We refer to this construct as V~2~R^ΔICL3^ and used it in subsequent experiments. Agonist stimulation of HEK-293T cells expressing V~2~R^ΔICL3^ resulted in robust generation of cAMP, and, of interest, the EC~50~ of cAMP generation for V~2~R^ΔICL3^ was ∼5- to 10-fold higher than that for wild type (WT), V~2~R^WT^ ([Figure 1D](#F1){ref-type="fig"}). This observation indicates relatively more efficient coupling of Gαs to V~2~R^ΔICL3^ than with V~2~R^WT^.

Next we tested whether V~2~R^ΔICL3^, potentially deficient in engaging the core interaction with βarrs, exhibits detectable physical interaction with βarr1. Confocal microscopy of HEK-293 cells expressing βarr1--yellow fluorescent protein (YFP) revealed robust interaction of V~2~R^ΔICL3^ with βarr1, as apparent by the formation of endocytotic vesicles upon agonist stimulation, similar to V~2~R^WT^ ([Figure 1E](#F1){ref-type="fig"}). This observation suggests that truncation of ICL3 and, presumably, therefore the loss of core interaction do not adversely affect the formation of a stable receptor--βarr1 complex in the cellular context. To further corroborate this finding and establish the lack of core engagement in the V~2~R^ΔICL3^-βarr1 complex, we expressed and purified V~2~R^WT^ and V~2~R^ΔICL3^ using cultured *Sf*9 cells. To trigger receptor phosphorylation and generate purified receptor protein harboring phosphorylated carboxyl terminus, we also coexpressed a membrane-tethered GRK2^CAAX^ construct in these cells. Before harvesting the cells for receptor purification, we stimulated them with agonist (AVP) to trigger V~2~R phosphorylation. Assembling a V~2~R-βarr1 complex in vitro was technically not feasible due to the transient nature of this complex, and therefore, to stabilize this complex, we used a previously described synthetic antibody fragment referred to as antigen-binding fragment 30 (Fab30). This Fab selectively recognizes an active conformation of βarr1 induced by the binding of V~2~Rpp (a phosphopeptide corresponding to the carboxyl terminus of V~2~R), and we successfully used it previously to assemble a stable complex of βarr1 with β~2~V~2~R in vitro ([@B32]; [@B16]). Using the ELISA-based approach depicted in [Figure 2A](#F2){ref-type="fig"}, we successfully reconstituted a stable complex of V~2~R^WT^ and βarr1 ([Figure 2, B--D](#F2){ref-type="fig"}). This complex is sensitive to receptor phosphorylation state, as agonist-bound but dephosphorylated receptor does not display stable complex formation even in the presence of Fab30 ([Figure 2B](#F2){ref-type="fig"}). In line with confocal microscopy data, V~2~R^ΔICL3^ also exhibited robust complex formation with βarr1, as assessed by ELISA ([Figure 2, C and D](#F2){ref-type="fig"}) and coimmunoprecipitation assay (coIP; [Figure 2, E and F](#F2){ref-type="fig"}). These observations taken together establish that a stable V~2~R^ΔICL3^-βarr1 complex can be reconstituted in vitro.

![V~2~R^ΔICL3^ interacts efficiently with βarr1 in vitro. (A) Schematic representation of an ELISA format for assembling V~2~R-βarr1 complex in vitro. Purified Fab30, an antibody fragment that selectively recognizes activated βarr1 conformation, is used as an anchor to stabilize the complex. Formation of the complex is visualized using M2 antibody against the FLAG tag at the N-terminus of the receptor. (B) Stable formation of V~2~R-βarr1 complex requires Fab 30 and is sensitive to receptor phosphorylation. Dephosphorylated receptor (with λ-phosphatase \[λ-Phos\]) does not exhibit detectable complex formation. Data from four independent experiments are normalized with respect to the basal signal observed without Fab30 immobilization (treated as 1) and analyzed using one-way analysis of variance (ANOVA) with Bonferroni posttest (\*\**p* \< 0.01). (C) Fab30-stabilized in vitro assembly of V~2~R^WT^-βarr1 complex as assessed by ELISA using cell lysate from *Sf*9 cells expressing V~2~R^WT^ following the protocol described in *Materials and Methods*. Here a fixed amount of Fab30 was first immobilized in the ELISA plate, followed by the addition of various amounts of V~2~R^WT^-βarr1 mixture and subsequent detection of complex formation by HRP-coupled M2 antibody. (D) Similar to V~2~R^WT^, V~2~R^ΔCL3^ also exhibits robust interaction with βarr1 upon stabilization using Fab30 as assessed by ELISA. Data in C and D represent two independent experiments each carried out in duplicate and normalized with respect to the maximal response (treated as 100%). (E) Fab30-stabilized formation of βarr1 complexes for V~2~R^WT^ and V~2~R^ΔICL3^ as assessed by coIP using purified proteins. The image is a representative blot of four independent experiments. (F) Densitometry-based quantification of V~2~R-βarr1-Fab30 complex formation using coIP data in E. Data are normalized with respect to the signal obtained for V~2~R^WT^ plus βarr1 condition (treated as 100%).](1003fig2){#F2}

Bimane fluorescence spectroscopy reveals lack of core interaction in the V~2~R^ΔICL3^-βarr1 complex
---------------------------------------------------------------------------------------------------

To test the status of the core engagement in the V~2~R^ΔICL3^-βarr1 complex, we used bimane fluorescence spectroscopy. As mentioned earlier, the finger loop of βarr1 is a key component of the core interaction with the receptor ([Figure 3A](#F3){ref-type="fig"}). Therefore we used a previously described single-cysteine mutant of βarr1 harboring a cysteine at position 68 in the finger loop, referred to as βarr1^L68C^ ([@B16]), and chemically labeled it with an environmentally sensitive fluorophore, monobromobimane (mBBr). We reasoned that the core interaction, which involves docking of the finger loop to the intracellular surface of the receptor, should lead to a change in fluorescence intensity and therefore can be used as a readout of the core interaction ([Figure 3A](#F3){ref-type="fig"}). In fact, finger loop--labeled visual arrestin has been used extensively to study its interaction with activated and phosphorylated rhodopsin ([@B35], [@B34]; [@B33]), and we have also used bimane labeled βarr1^L68C^ to investigate the core interaction between the β~2~V~2~R and βarr1 ([@B16]). In line with our hypothesis, interaction of V~2~R^WT^ with bimane-labeled βarr1 led to a significant quenching of the fluorescence intensity, indicating core engagement ([Figure 3, B and C](#F3){ref-type="fig"}). In contrast, interaction of V~2~R^ΔICL3^ did not yield any detectable decrease in bimane fluorescence, although it forms a physically stable complex with βarr1, as presented in [Figure 2, C--F](#F2){ref-type="fig"}. As a control, incubation of inactive and nonphosphorylated V~2~R, which does not interact with βarr1, did not change the bimane fluorescence in this assay. Taken together, these data establish that the V~2~R^ΔICL3^-βarr1 complex is associated only through the carboxyl terminus and does not engage the core interaction. Therefore V~2~R^WT^-βarr1 and V~2~R^ΔICL3^-βarr1 complexes represent fully engaged (i.e., core plus tail) and partially engaged (i.e., tail alone) complexes, respectively.

![Fluorescence spectroscopy reveals that V~2~R^ΔICL3^-βarr1 complex lacks the core interaction. (A) Schematic representation of bimane fluorescence quenching assay as a readout of the core interaction between V~2~R and βarr1. The finger loop of βarr1 is labeled with mBBr, and the core interaction with receptor leads to a decrease in bimane fluorescence intensity. (B) Bimane fluorescence of βarr1 decreases upon its interaction with V~2~R^WT^ suggesting the engagement of the core interaction. Of interest, however, for V~2~R^ΔICL3^, there is no decrease in bimane fluorescence, suggesting the lack of core interaction, which confirms that the V~2~R^ΔICL3^-βarr1 complex is partially engaged, that is, associated only through the receptor tail. Here V~2~R-βarr1 complexes are stabilized with Fab30, and AVP and tolvaptan were used as agonist and inverse agonist, respectively. Purified receptors are preincubated with excess molar concentration of indicated ligands, followed by incubation with βarr1^mBBr^ and Fab30. (C) Bimane fluorescence intensity at λ~max~ as measured in B. Data were analyzed using one-way ANOVA with Bonferroni posttest (\*\*\**p* \< 0.001). Data in B and C represent an average of three independent experiments.](1003fig3){#F3}

Partially engaged V~2~R^ΔICL3^-βarr1 complex binds clathrin and supports receptor internalization
-------------------------------------------------------------------------------------------------

As mentioned earlier, one of the key functions of βarrs is to mediate clathrin-dependent endocytosis of GPCRs upon agonist stimulation ([@B12]). βarrs bind to clathrin heavy chain and facilitate the trafficking of activated receptors in clathrin-coated vesicles ([@B7]). Therefore, to test the functional competence of partially engaged V~2~R^ΔICL3^-βarr1 complex (i.e., associated only through the receptor tail), we first measured its interaction with the clathrin heavy-chain terminal domain (TD). We used a single-chain version of Fab30, referred to as ScFv30, to stabilize V~2~R^WT^-βarr1 and V~2~R^ΔICL3^-βarr1 complexes to avoid potential steric clash with clathrin binding. As presented in [Figure 4, A and B](#F4){ref-type="fig"}, coIP revealed that even the partially engaged complex (V~2~R^ΔICL3^-βarr1) binds effectively to clathrin TD, similar to the fully engaged complex (V~2~R^WT^-βarr1). Of greater importance, assessment of agonist-triggered receptor internalization in HEK-293 cells also revealed comparable endocytosis of V~2~R^WT^ and V~2~R^ΔICL3^ ([Figure 4C](#F4){ref-type="fig"}). These findings suggest that the core interaction in V~2~R-βarr1 complex is dispensable for clathrin binding and βarr-mediated receptor internalization.

![V~2~R^ΔICL3^-βarr1 complex binds clathrin, and V~2~R^ΔICL3^ undergoes efficient endocytosis. (A) A coIP experiment reveals that V~2~R^ΔICL3^-βarr1 complex (partially engaged) is able to interact with GST-clathrin-TD, similar to V~2~R^WT^-βarr1 complex (fully engaged). Here ScFv30 is used to stabilize V~2~R-βarr1 complexes to avoid any potential clash with clathrin binding. Purified GST is used as a negative control. A representative image of four independent experiments. (B) Densitometry-based quantification of coIP data in A. Data are normalized with respect to clathrin interaction with V~2~R^WT^-βarr1 complex (treated as 100%). (C) Agonist-induced endocytosis of V~2~R^WT^ and V~2~R^ΔICL3^ are comparable, suggesting that the inability of V~2~R^ΔICL3^ to engage the core interaction with βarr does not affect receptor endocytosis. Here HEK-293 cells expressing either V~2~R^WT^ or V~2~R^ΔICL3^ were stimulated with 100 nM AVP (agonist) for indicated times, and the loss of surface receptor as measured by reactivity of HRP-coupled M2 antibody with N-terminal FLAG tag in whole-cell ELISA was used as a readout of receptor endocytosis. Data represent average ± SEM of six independent experiments each carried out in duplicate.](1003fig4){#F4}

Partially engaged V~2~R^ΔICL3^-βarr1 complex binds ERK MAPK and supports ERK activation
---------------------------------------------------------------------------------------

In addition to classical G protein--dependent signaling, parallel signaling pathways mediated by βarrs have also been identified for a number of GPCRs, and it has now become a generally applicable paradigm in the GPCR family ([@B19]; [@B5]). βarrs can nucleate various signaling assemblies to facilitate their activation and trigger specific signaling pathways ([@B21]; [@B25]; [@B20]). For example, βarrs can scaffold various components of ERK MAPK cascade, such as Raf1, MEK1, and ERK2, which leads to ERK phosphorylation and activation ([@B5]; [@B4]; [@B10], [@B11]). Therefore we first investigated the ability of the partially engaged complex to interact with inactive (nonphosphorylated) and active (phosphorylated) ERK2. Similar to clathrin binding, we observed that the partially engaged complex (V~2~R^ΔICL3^-βarr1; stabilized by ScFv30) robustly interacted with inactive and active ERK2, similar to fully engaged complex ([Figure 5, A and B](#F5){ref-type="fig"}). Agonist-induced ERK activation downstream of GPCRs exhibits a biphasic pattern in which the early phase depends primarily on G protein activation, whereas the late phase is mediated primarily by βarrs ([@B5]). This temporal pattern of ERK activation has been directly visualized for V~2~R as well, using H-89 (PKA inhibitor) and small interfering RNA--mediated knockdown of βarrs ([@B29]). ERK activation after 5 min of agonist stimulation was sensitive to H-89, indicating predominant dependence on Gαs (and cAMP), whereas that at 10 min and beyond was sensitive to βarr knockdown ([@B29]). Therefore we measured agonist-induced ERK activation in HEK-293 cells expressing V~2~R^ΔICL3^ or V~2~R^WT^ and observed that they displayed comparable levels of ERK activation at 5, 15, and 30 min after agonist stimulation ([Figure 5, C and D](#F5){ref-type="fig"}). These findings suggest that, similar to clathrin binding and receptor endocytosis, interaction of ERK2 and βarr-dependent ERK activation also do not require core engagement between βarr and V~2~R.

![V~2~R^ΔICL3^-βarr1 complex binds ERK2, and V~2~R^ΔICL3^ exhibits efficient ERK activation. (A) V~2~R^ΔICL3^-βarr1 complex interacts efficiently with inactive (i.e., nonphosphorylated) and active (i.e., phosphorylated) ERK2, similar to V~2~R^WT^-βarr1 complex, as assessed by a coIP experiment. Here ScFv30 is used to stabilize V~2~R-βarr1 complexes to avoid any potential clash with ERK2 binding. Purified GST is used as negative control. Representative image of three independent experiments. (B) Densitometry-based quantification of coIP data presented in A, showing the interaction of inactive and active ERK2 with preformed V~2~R^WT/ΔICL3^-βarr1 complexes. Data are normalized with respect to the signal observed for the interaction of inactive ERK2 with V~2~R^WT^-βarr1 complex (treated as 100%). (C) Agonist (100 nM AVP)-stimulated ERK activation in HEK-293 cells expressing V~2~R^WT^ or V~2~R^ΔICL3^ as measured by Western blotting. V~2~R^ΔICL3^ exhibits efficient ERK activation similar to V~2~R^WT^, indicating that the lack of core interaction with βarr does not influence ERK phosphorylation. A representative image from six independent experiments. (D) Densitometry-based quantification of agonist-induced ERK phosphorylation in C. Data represent average ± SEM of six independent experiments normalized with respect to signal at 5 min for V~2~R^WT^ (treated as 100%).](1003fig5){#F5}

Interaction of βarrs with activated and phosphorylated receptors is a hallmark of GPCR family members. Although primary sequence of GPCRs is not highly conserved, most of them, if not all, undergo agonist-induced phosphorylation and display conserved conformational rearrangement during activation ([@B24]). These two features are most likely responsible for βarrs interacting with and regulating a large repertoire of GPCRs. It is also interesting that functional aspects of the GPCR-βarr interaction, such as receptor desensitization, endocytosis, and G protein--independent signaling, are also mostly conserved. Comparison of rhodopsin--arrestin-1 fusion protein crystal structure ([@B14]) and β~2~AR-Gs crystal structure ([@B28]) reveals significant overlapping interface for arrestin and Gαs binding on the receptor and corroborates a steric hindrance--based receptor desensitization mechanism. In this context, it is interesting that EC~50~ of agonist-induced cAMP generation for V~2~R^ΔICL3^ is about an order of magnitude higher than that of V~2~R^WT^ ([Figure 1D](#F1){ref-type="fig"}). This suggests more efficient G protein coupling and/or less efficient desensitization of V~2~R^ΔICL3^ than with V~2~R^WT^ and therefore directly indicates that the core interaction with βarr is critical for mediating receptor desensitization.

The crystal structure of βarr1 in complex with V~2~Rpp directly reveals major conformational changes in βarr1 consistent with the notion that interaction of receptor attached phosphates can drive an "active-like" βarr conformation ([@B31]). Furthermore, direct visualization of a stable, tail only--engaged β~2~V~2~R-βarr1 complex ([@B32]) and previous studies demonstrating enhanced clathrin binding to V~2~Rpp-occupied βarrs ([@B39]; [@B26]) raise the possibility that even partially engaged intermediates during biphasic GPCR-βarr interaction might be able to drive some of the βarr functions. Here we discover that a complex of βarr1 with a V~2~R mutant lacking the core interaction can efficiently bind clathrin and ERK MAPK. Moreover, this V~2~R mutant also efficiently undergoes agonist-dependent internalization and triggers ERK MAPK activation identical to the WT receptor in cells. As mentioned earlier, most signaling and regulatory paradigms in GPCR family are generally conserved. Therefore it is tempting to speculate that the dispensability of the core interaction for at least some of the functional outcomes might also be applicable to other receptors. Considering the broad functional repertoire of βarrs, it would also be very interesting to investigate whether majority of βarr functions other than desensitization can be mediated by partially engaged complexes.

In conclusion, our data establish that even a partially engaged V~2~R-βarr complex lacking the core interaction is functional with respect to receptor endocytosis and ERK activation. Our findings also support the requirement of core interaction for steric hindrance--based receptor desensitization. Taken together, our observations reveal a functional segregation associated with the tail and the core interaction between GPCRs and βarrs and provide novel insights into biphasic GPCR-βarr interaction. As mentioned earlier, a key aspect of the broad functional repertoire of βarrs is their ability to scaffold a large number of interaction partners, and therefore it would be interesting to explore which of these interactions and corresponding functions, if any, might still require a core interaction between GPCRs and βarrs.

MATERIALS AND METHODS
=====================

General chemicals, plasmids, cell culture, and recombinant protein expression
-----------------------------------------------------------------------------

General reagents used in this study were purchased from Sigma-Aldrich unless specified otherwise. Antibodies used in this study were anti-FLAG M2--horseradish peroxidase (HRP) conjugated (A8592; Sigma-Aldrich), anti-pERK2 (1:5000; 9101 Cell Signaling Technology), and anti-tERK2 (1:5000; 9102; Cell Signaling Technology). The coding region of the human V~2~R was synthesized (GenScript) and cloned into pcDNA3.1 with an N-terminal FLAG tag, and V~2~R^ΔICL3^ construct was generated using overlap extension PCR. Plasmid constructs for bacterial expression of Fab30, ScFv30, βarr1, βarr1^L68C^, clathrin (TD), and ERK2 were described previously ([@B16]). The βarr1-YFP plasmid construct for expression in HEK-293 cells was also described earlier ([@B16]). All constructs were sequence validated (Macrogen).

HEK-293 cells were grown in DMEM (Sigma-Aldrich), maintained under 5% CO~2~, and transfected with polyethylenimine (PEI) using standard protocols. For purification of phosphorylated V~2~R^WT^ and V~2~R^ΔICL3^, receptor-coding regions were first subcloned into pVL1393 with N-terminal FLAG tag, and baculovirus stocks were generated using standard protocols (Expression Systems). Cultured *Sf*9 cells were infected with virus stocks corresponding to either the V~2~R^WT^ or V~2~R^ΔICL3^ together with GRK2^CAAX^ at a density of 1.5 × 10^6^ cells/ml. At 60--66 h postinfection, cells were stimulated with 100 nM AVP for 1 h at 37°C to induce receptor phosphorylation and subsequently harvested by centrifugation. Recombinant receptors were solubilized with maltose neopentyl glycol (MNG; 0.5% wt/vol) and purified using anti-FLAG M1 antibody affinity resin following a similar protocol as described previously for β~2~V~2~R ([@B16]). Purified receptor preparations were flash frozen with 10% glycerol and stored at −80°C until further use.

Whole-cell ELISA for measuring surface expression of V~2~R^WT^ and V~2~R^ΔICL3^
-------------------------------------------------------------------------------

Surface and total expression of V~2~R constructs were measured using a previously published whole-cell ELISA-based protocol ([@B16]). This assay essentially measures the reactivity of an anti-FLAG M2 antibody to cells expressing N-terminal FLAG-tagged receptor constructs. Here the signal arising from nonpermeabilized cells indicates surface expression, and the signal arising from permeabilized cells represent total (surface plus internal) receptor levels. HEK-293 cells were transfected with either WT V~2~R or various truncated V~2~R constructs (as indicated in [Figure 1C](#F1){ref-type="fig"}) using PEI. At 24 h posttransfection, cells were seeded into poly-[d]{.smallcaps}-lysine--coated 24-well plates. After another 24 h, cells were serum starved for 1 h, washed with ice-cold Tris-buffered saline (TBS), fixed with 4% (wt/vol) paraformaldehyde (PFA) on ice, and washed again with TBS. Afterward, cells were incubated with blocking buffer (TBS plus 1% bovine serum albumin \[BSA\]) for 90 min at room temperature. To measure total receptor expression, cells were permeabilized with 0.01% Triton X-100 during the blocking step. Subsequently cells were incubated with HRP-coupled anti-FLAG M2 antibody (1.5--2 h at room temperature) and then washed three times with TBS plus 1% BSA. Finally, receptor expression was visualized by adding 3,3′,5,5′-tetramethylbenzidine (TMB) ELISA, and the reaction was stopped by adding 1 M H~2~SO~4~. Signal intensities were taken at 450 nm. For normalization of total cell numbers in each well, cells were washed with TBS (after TMB ELISA signals were measured), incubated with 0.2% (wt/vol) Janus Green dye (mitochondrial stain) for 10 min, and then destained with water. The color was developed by adding 0.5 M HCl, and the absorbance was measured at 595 nm. The ratio of *A*~450~ (TMB ELISA) to *A*~595~ (Janus Green) was used to calculate surface and total expression of V~2~R constructs ([Figure 1C](#F1){ref-type="fig"}). Overall surface expression levels of V~2~R^WT^ and V~2~R^ΔICL3^ were comparable.

GloSensor assay
---------------

To measure agonist-induced G protein coupling and cAMP generation for V~2~R^WT^ and V~2~R^ΔICL3^ ([Figure 1D](#F1){ref-type="fig"}), HEK-293T cells were cotransfected with plasmids for the receptor and the luciferase-based cAMP biosensor (total 0.1 µg/well in 96-well plate; pGloSensorTM-22F plasmid; Promega) using PEI. Transfected cells were incubated for 14--16 h, followed by removal of the cell culture medium and addition of 100 µl of sodium luciferin solution to cells in ligand buffer (1× Hanks balanced salt solution, pH 7.4, and 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid \[HEPES\]). Subsequently plates were incubated at 37°C for 90 min, and then indicated concentrations of AVP (100 nM to 0.1 pM serially diluted in half log) were added to cells. After an additional incubation for 10--15 min, luminescence readings in wells were recorded using a luminescence plate reader (BMG LabTech). Data were corrected with respect to vehicle control, and normalized with respect to maximal stimulation by agonist (treated as 100%). Data were plotted and analyzed using nonlinear regression in GraphPad Prism software.

Confocal microscopy
-------------------

For visualization of agonist-stimulated recruitment of βarr1-YFP ([Figure 1E](#F1){ref-type="fig"}), transfected HEK-293 cells were seeded onto 0.001% poly-[d]{.smallcaps}-lysine--coated glass coverslips and serum starved for 4 h. Cells were then stimulated with 100 nM AVP for the indicated time point, fixed using 4% PFA, and permeabilized with 0.01% Triton X-100. For nuclear staining, 0.5 μg/ml 4′,6-diamidino-2-phenylindole solution (Sigma-Aldrich) was added to fixed cells. After a final wash with PBS, coverslips were mounted onto glass slides using VectaShield H-1000 mounting medium (VectaShield), allowed to air dry for 15 min, and then imaged using an LSM780NLO confocal microscope (Carl Zeiss).

Formation of V~2~R^WT^-βarr1 and V~2~R^ΔICL3^-βarr1 complexes and their interaction with clathrin and ERK2
----------------------------------------------------------------------------------------------------------

These complexes were assembled in ELISA and coIP format following a previously published experimental setup ([@B16]). Briefly, for ELISA-based assembly ([Figure 2, A--D](#F2){ref-type="fig"}), purified Fab30 was first immobilized in a MaxiSorp ELISA plate, followed by incubation of wells with 5% BSA to block nonspecific binding. Subsequently lysates from *Sf*9 cells expressing recombinant receptor constructs and purified βarr1 were added to immobilized Fab30 in ELISA plates. *Sf*9 cells were stimulated with agonist (AVP, 100 nM) before preparation of the lysate in order to induce receptor activation and phosphorylation. As a control, cell lysate was incubated with λ-phosphatase to remove receptor phosphorylation ([Figure 2B](#F2){ref-type="fig"}). Subsequently the plate was incubated at room temperature (25°C) for 1 h, followed by extensive washing of the wells and incubation with HRP-coupled anti-FLAG M2 antibody (1:2000) for 1 h. After additional washing, signal was detected using TMB ELISA solution (GenScript), the reaction was stopped by adding 1 M H~2~SO~4~, and the signal was recorded at 450 nm in a multimode Plate Reader (PerkinElmer). For the saturation-binding experiment in [Figure 2, C and D](#F2){ref-type="fig"}, immobilized Fab30 was incubated with various concentrations of the receptor (in the form of cell lysate) and βarr1 (purified protein). For these experiments, ∼24 ml of *Sf*9 cells (60--66 h postinfection) were lysed in 1.5 ml of lysis buffer (20 mM HEPES, pH 7.4, 100 mM NaCl, 0.5% MNG) and mixed with 80--100 μg of βarr1, and indicated volumes of lysate plus βarr1 mixture were added to each well of the ELISA plate.

To assess the formation of V~2~R-βarr1 complexes in solution by coIP ([Figure 2E](#F2){ref-type="fig"}), purified V~2~R (WT and ΔICL3) was mixed with purified βarr1 and Fab30 and incubated at room temperature for 1 h; subsequently 20 μl of protein L beads was added. Afterward, beads were washed three times (20 mM HEPES, pH 7.4, 100 mM NaCl, 0.01% MNG), eluted with SDS loading buffer, and used for Western blotting--based detection of V~2~R-βarr1 interaction.

To measure the binding of clathrin and ERK2 with preformed complexes ([Figures 4, A and B](#F4){ref-type="fig"}, and [5, A and B](#F5){ref-type="fig"}), purified glutathione *S*-transferase (GST)--clathrin-TD/GST-ERK2/GST-pERK2 were first captured on GS beads, followed by incubation with preformed V~2~R-βarr1-ScFv30 complexes. After three rounds of washing, bound proteins were eluted in SDS loading buffer and probed by Western blotting using HRP-coupled anti-FLAG M2 antibody. Purified GST was used as a control for nonspecific binding of the complex to GS beads. Densitometry-based quantification of coIP data are normalized with respect to signal observed for V~2~R^WT^, which is treated as 100% ([Figures 4B](#F4){ref-type="fig"} and [5B](#F5){ref-type="fig"}).

Bimane fluorescence spectroscopy
--------------------------------

We previously described a detailed protocol for bimane fluorescence spectroscopy using bimane-labeled βarr1 ([@B16]). Essentially, purified βarr1^L68C^ was labeled with mBBr (Sigma-Aldrich), and unreacted mBBr was separated on a PD10 desalting column (GE Healthcare). For fluorescence experiments, mBBr labeled βarr1^L68C^ was used at an approximate final concentration of 2 μM and mixed with threefold molar excess (6 μM) of purified V~2~R (WT or ΔICL3) and Fab30 for 60 min at room temperature (25°C). Here V~2~R was purified from agonist-stimulated cells to generate active and phosphorylated receptor. As a negative control, we also purified V~2~R^WT^ from inverse agonist-treated cells (inactive and nonphosphorylated). Fluorescence scanning analysis was performed using a fluorometer (model LS-55; PerkinElmer) in photon counting mode by setting the excitation and emission band-pass filter of 5 nm. For emission scan, excitation was set at 397 nm, and emission was measured from 415 to 600 nm with a scan speed of 50 nm/min. Bimane fluorescence intensities in each experiment were normalized with respect to βarr1 plus Fab30 condition, which was treated as 100% ([Figure 3, B and C](#F3){ref-type="fig"}). Fluorescence intensity was also corrected for background fluorescence from buffer and protein in all experiments, and each experiment was repeated at least twice.

Receptor endocytosis and ERK assay
----------------------------------

Agonist-induced receptor internalization ([Figure 4C](#F4){ref-type="fig"}) was measured using essentially the same protocol as described for measuring receptor surface expression. The only modification was that after serum starvation, cells were stimulated with AVP (100 nM) for indicated times. The values were normalized with respect to 0-min signal, which was treated as 100%. Data in [Figure 4C](#F4){ref-type="fig"} represent the average ± SEM of six independent experiments, each performed in duplicate.

For measuring agonist- induced ERK phosphorylation ([Figure 5, C and D](#F5){ref-type="fig"}), transfected HEK-293 cells were serum starved for 4--6 h and then stimulated with 100 nM AVP for indicated times. Afterward, cells were lysed in 100 µl of 2× SDS loading buffer and sonicated, and lysates were separated by 12% SDS--PAGE. Subsequently Western blotting was performed to assess the phosphorylation of ERK1/2 using phospho-ERK primary antibody (9101; Cell Signaling Technology) overnight at 4°C, followed by 1 h of incubation with anti-rabbit immunoglobulin G secondary antibody (A00098; GenScript) at room temperature. The membrane was then washed with 1× TBST three times and developed using ChemiDoc set-up (Bio-Rad). Phospho-ERK antibody was stripped off using 1× stripping buffer, and then the membrane was reprobed with total ERK antibody (9102, Cell Signaling Technology).

Data analysis
-------------

Experimental data were plotted using GraphPad Prism software. Data were analyzed using appropriate statistical analysis, as indicated in the figure legends, which also give the data normalization.
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βarr

:   β-arrestin

EC~50~

:   concentration of a drug that gives half-maximal response

ELISA

:   enzyme-linked immunosorbent assay

ERK

:   extracellular signal-regulated kinase

Fab

:   antigen-binding fragment

GPCR

:   G protein--coupled receptor

ICL3

:   third intracellular loop

MAPK

:   mitogen-activated protein kinase
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